CRYOPORT, INC. Construction in Progress, Gross
CRYOPORT, INC. (CYRX) had Construction in Progress, Gross of $24.22 million as of 2023-12-31, per its 10-K filed 2024-03-13.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:ConstructionInProgressGross · last filed 2024-03-13
- 2023-12-31: Construction in Progress, Gross $24.22M.
- 2022-12-31: Construction in Progress, Gross $15.95M.
- 2021-12-31: Construction in Progress, Gross $8.58M.
- 2020-12-31: Construction in Progress, Gross $8.07M.
| Period end | Construction in Progress, Gross | Construction in Progress, Gross as first filed |
|---|---|---|
| 2023-12-31 | $24.22M 10-K · filed 2024-03-13 | |
| 2022-12-31 | $15.95M 10-K · filed 2024-03-13 | |
| 2021-12-31 | $8.58M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $8.07M 10-K · filed 2022-02-28 | |
| 2019-12-31 | $3.41M 10-K · filed 2021-03-01 | $3.41M 10-K · filed 2020-03-10 |
| 2018-12-31 | $1.37M 10-K · filed 2020-03-10 | |
| 2017-12-31 | $568.69K 10-K · filed 2019-03-13 | |
| 2016-12-31 | $106.60K 10-K · filed 2018-03-08 | |
| 2016-03-31 | $0.00 10-KT · filed 2017-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |